In 1998, there have been two new Epstein-Barr virus test kits made available --

June 03, 1998

A new diagnostic test for the Epstein-Barr virus, which can cause mononucleosis and may be associated with some cases of CFS, has been approved for marketing by the U.S. Food and Drug Administration. The new test, which is manufactured by Trinity Biotech Plc, not only identifies the presence of EBV antibodies as current tests do, but also identifies the stages of disease development due to EBV infection. It is possible that the new test could provide doctors with more information about the relationship between EBV and CFS.

Monday, August 24, 1998

Gull Laboratories and Quest Diagnostics jointly announced today that Quest's new test kit for the Epstein-Barr virus will be supplied by Gull on a three-year contract to begin on September 1, 1998. EBV has been associated with some cases of chronic fatigue syndrome. The new test not only detects the presence of antibodies to the virus, but is also capable of detecting whether the infection is in the acute, convalescent or reactivated stage.

The press release did not give an exact date when the kits would be available to the public, but Quest says it expects to perform over half a million tests the first year, and 20 percent more each year after that.

Source of information:
PRNewswire release by Gull Laboratories, Inc.

* * * * * * * * * * * * * * * * * * *
From: "Linda Clement"
Cfsmail is a free e-mail news service for chronic fatigue syndrome, fibromyalgia,
and related disorders, symptoms, and issues.
* * * * * * * * * * * * * * * * * * *

Web page design by Bill Jackson, 1998.

Any comments? Send them to Bill Jackson at

Button pointing leftBack to CFS Index Page